3172 results for «358»
3172 results
Management of coronary aneurysms
18 Dec 2024 – From GulfPCR-GIM 2024
Explore this session to discover innovative approaches to the management of complex coronary aneurysms. From contrast-induced nephropathy prevention using a balloon angiography system to rescue techniques for wire fracture during atherectomy, you'll gain insights into navigating challenging scenarios. Dive deeper into the percutaneous exclusion of a...
Optimisation of immediate and long-term outcomes using a novel self-expanding valve
18 Dec 2024 – From GulfPCR-GIM 2024
Explore the features and benefits of the ACURATE neo2, a novel self-expanding valve, through clinical cases and recorded procedures. Gain insights into step-by-step implantation techniques, the latest evidence in TAVI, and outcomes from immediate to long-term, focusing on lifetime patient management.
Wireless physiology assessment
22 May 2025 – From EuroPCR 2025
This session examines the evolving field of wireless physiology assessment in PCI. Topics include randomized trials comparing angiography and physiology guidance, prognostic performance of imaging-derived physiology, and outcomes in various patient subsets including elderly patients with multivessel disease.
Beyond angiography: imaging-guided solutions for stent failure
22 May 2025 – From EuroPCR 2025
Stent failure remains a critical challenge in interventional cardiology — but intracoronary imaging can change the outcome. This session goes beyond angiography to examine why stents fail, how to detect underlying causes, and how imaging-guided strategies can help tailor reintervention. Two real-life cases, from complex restenosis...
Complications in STEMI : dissections and more
21 May 2025 – From EuroPCR 2025
Address complications encountered in STEMI interventions such as dissections and coronary perforations. Learn from case presentations highlighting procedural challenges, management of delayed perforations, and balancing procedural perfection with practical outcomes.
OHCM, ablation complications: interventional solutions
21 May 2025 – From EuroPCR 2025
Explore interventional solutions for complications arising in obstructive hypertrophic cardiomyopathy (OHCM) and ablation procedures. Cases include complex congenital anomalies, novel non-invasive treatments, dual pulmonary vein stenosis, iatrogenic fistulas, and ablation-related cardiac defects.
Calcium modification: contemporary comparaisons of atherectomy and IVL
22 May 2025 – From EuroPCR 2025
Compare contemporary calcium modification techniques including atherectomy and intravascular lithotripsy (IVL) in complex coronary lesions. Review clinical outcomes, procedural case studies, and registry data highlighting safety and efficacy in acute coronary syndrome and high-risk patients.
SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk
07 Nov 2021
Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...
Author
Author
World Heart Day 2023: Reducing the burden of cardiovascular disease globally: beyond stents and balloons!
29 Sep 2023
Global burden of Cardiovascular Disease
Cardiovascular disease (CVD) remains the lead cause of mortality for men and women globally. Our world population in 2023 is 8 billion! Of these, around 620 million people are living with heart and circulatory diseases across the world. Each year around 60...
Author
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
07 Nov 2022
Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.
This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...
Author
The Lancet Commission to reduce global burden of cardiovascular disease in women by 2030
29 Aug 2021
Vijay Kunadian summarizes the key points of the LBT session of the ESC congress 2021 held on Sunday, 29 August focusing on the Lancet Commission to reduce the global burden of heart disease in women by 2030.
Author
Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions
08 Jan 2025
In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.
Author
